World Health Organization (WHO) Provides Urgent Medical Support to Ghana to Combat Meningitis Outbreak
Ghana is experiencing a worsening bacterial meningitis outbreak in the Upper West Region, straining the country's healthcare system as cases continue to climb. With limited resources and rising fatalities, health authorities are racing against time to contain the disease and provide critical treatment to those affected. In response to the escalating crisis, the World Health Organization (WHO) has stepped in to provide much-needed technical and logistical support.
As cases increased from 42 to 60, with 14 reported deaths, WHO donated 10,600 vials of Ceftriaxone, a potent antibiotic used in meningitis treatment. The donation, valued at approximately $23,000, was officially received by the Minister of Health, Hon. Kwabena Mintah Akandoh, at a brief ceremony in Accra. The Minister immediately handed over the vials to the Director-General of the Ghana Health Service (GHS), Prof. Samuel Kaba Akoriyea, for swift deployment to affected communities.
Speaking at the handing over of the items, Dr. Frank Lule, Officer in Charge of WHO Ghana, reaffirmed WHO's commitment to Ghana's health systems. He said, 'This donation is another testament to WHO's commitment to strengthening Ghana's health systems. If additional vials are needed, we will be here to provide more support.'
Hon. Kwabena Mintah Akandoh, Minister of Health, emphasized the importance of WHO's support, saying: 'We are currently managing several outbreaks, and this timely donation is crucial. I'm about to brief Ghana's Parliament on our response and will highlight WHO's support.'
In addition to medical supplies, WHO has dispatched Dr. Nicolō Binello, a Technical Officer specializing in Meningitis and Epidemic Bacterial Diseases from its headquarters in Geneva. Dr. Binello will work closely with national and local health authorities to strengthen clinical care and response strategies, ensuring effective treatment for patients and mitigating further spread of the disease.
Prof. Samuel Kaba Akoriyea, Director-General of Ghana Health Service, assured that the donation would be put to immediate use. 'This donation will go directly to the affected areas. WHO has also deployed a technical officer to support Ghana's meningitis response. We are truly grateful', he said.
As part of its response, the Ghana Health Service has intensified public education campaigns, urging citizens to seek medical care at the earliest signs of meningitis symptoms. Additionally, treatment for meningitis is being offered free of charge in all health facilities to eliminate financial barriers and reduce mortality rates.
The ongoing collaboration between WHO, Ghanaian health authorities, and local communities highlights a unified commitment to addressing the meningitis outbreak. Through strategic interventions, expert deployment, and resource mobilization, efforts are being intensified to curb the disease and safeguard public health.
Distributed by APO Group on behalf of WHO Regional Office for Africa.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Sharjah 24
2 hours ago
- Sharjah 24
WHO warns of rising COVID-19 cases linked to new variant
No increased health risk, but caution urged Although the WHO has confirmed that the new variant does not present a higher health risk compared to earlier strains, it stressed that the virus's continued evolution could trigger new waves of infection in the future. Seasonal pattern and immunity help limit severe cases The organisation noted that the current increase in cases is consistent with the virus's seasonal trends. However, the need for hospitalisation or intensive care remains limited, thanks to strong community immunity and widespread vaccine coverage. WHO calls for vigilance and stronger surveillance Despite the limited severity, the WHO has classified the global risk level as 'high' and called on countries to enhance health surveillance, integrate COVID-19 into seasonal respiratory illness planning, counter misinformation, and encourage the public to follow preventive guidelines.
Gulf Today
2 hours ago
- Gulf Today
WHO warns of rising COVID-19 cases due to new variant
The World Health Organisation (WHO) has warned of a rise in COVID-19 infections linked to the emergence of a new variant, NB.1.8.1, which is currently under investigation. While the organisation confirmed that the new variant does not pose a greater health risk than previous strains, it noted that the continued evolution of the virus could lead to new waves of infection. WHO stated that the current increase aligns with the virus's seasonal pattern and emphasised that the need for hospitalisation or intensive care remains limited due to widespread community immunity and vaccination coverage. The global health body classified the overall global risk level as "high', urging countries to strengthen health surveillance, integrate COVID-19 into seasonal respiratory disease strategies, combat misinformation, and encourage individuals to adhere to preventive measures. WAM
Khaleej Times
4 hours ago
- Khaleej Times
Man who let snakes bite him 200 times spurs new antivenom hope
Tim Friede was feeling particularly down on the day after the September 11 attacks, so he went to his basement and let two of the world's deadliest snakes bite him. Four days later, he woke up from a coma. "I know what it feels like to die from snakebite," Friede told AFP via video call from his home in the small US town of Two Rivers, Wisconsin. This experience might put most people off snakes entirely, but Friede simply vowed to be more careful next time. From 2000 to 2018, he allowed himself to be bitten by snakes more than 200 times. He also injected himself with their venom over 650 times. Friede endured this pain because he wanted to achieve total immunity to venom, a practice called mithridatism which should not be tried at home. After a couple of years, Friede started to believe he could be the basis for a better kind of antivenom. The former truck mechanic, who does not have a university degree, long struggled to be taken seriously by scientists. But last month, a study published in the prestigious Cell journal showed that antibodies from his blood protect against a range of snake venom. The researchers now hope Friede's hyper-immunity could even lead to the development of a universal antivenom. This would fill a major need, because currently most antivenoms only cover one or a few of the world's 600 venomous snakes. Up to 138,000 people are killed by snakebites a year, while 400,000 suffer amputations or other disabilities, according to the World Health Organization. These figures are believed to be vastly underestimated because snakebite victims typically live in poorer, remote areas. 'Pain every time' Friede's first bite was from a harmless garter snake when he was five years old. "I was afraid, I cried, I ran away," said Friede, now 57. Then he started bringing snakes home and hiding them in pickle jars. His mother sought counselling, but his interest in snakes persisted. Things escalated after Friede attended a class that taught him how to "milk" snakes for their venom. How antivenom is made has changed little over the last 125 years. Small doses of snake venom are injected into animals such as horses, which produce antibodies that can be extracted and used as antivenom. However this antivenom usually only works for bites from that particular species of snake -- and it includes other antibodies from horse that can cause serious side-effects including anaphylactic shock. "I thought, well, if they make antivenom in horses, why can't I just use myself as a primate?" Friede said. He started working through the venom from all the deadly species he could get his hands on, such as cobras, taipans, black mambas and rattlesnakes. "There is pain every time," he said. 'Proud' For years, the scientists he contacted to take advantage of his immunity refused to bite. Then in 2017, immunologist Jacob Glanville, who previously worked on universal vaccines, turned his attention towards antivenom. Glanville told AFP he had been looking for "a clumsy snake researcher who'd been bit accidentally a couple times," when he came across a video of Friede taking brutal back-to-back snake bites. When they first spoke, Glanville said he told Friede: "I know this is awkward, but I would love to get my hands on some of your blood." "I've been waiting for this call for a long time," came the response, Glanville said. The antivenom described in the Cell paper includes two antibodies from Friede's blood, as well as a drug called varespladib. It offered mice full protection against 13 of the 19 snake species tested, and partial protection for the remaining six. The researchers hope a future cocktail will cover far more snakes -- particularly vipers -- with further trials planned on dogs in Australia. Timothy Jackson of the Australian Venom Research Unit praised the immunological research, but questioned whether a human needed to be involved, pointing to synthetically developed antibodies. Glanville said the ultimate goal of his US-based firm Centivax was to develop a universal antivenom administered by something like an EpiPen, potentially produced in India to keep the costs down. Friede said he was "proud" to have made a "small difference" in medical history. Now working for Centivax, Friede stopped self-inflicting himself with venom in 2018 to save the firm from liability issues. But he hopes to get bitten by snakes again in the future. "I do miss it," he said.
